Overview
InnovaHealth Partners, LP (“IHP” or “Adviser”) is a Delaware limited partnership formed in
December 2016. The Firm is led by three investment principals, Mortimer “Tim” Berkowitz III,
Ariella Golomb, MD, and John C. McCormick (each a “Principal” and collectively, the
“Principals”). The Principals also control InnovaHealth Partners GP, LLC, the Adviser’s general
partner. The Adviser serves as the investment adviser to a single private pooled investment vehicle
for sophisticated investors, InnovaHealth Partners Fund, LP (the “Fund”), and related co-
investment vehicles (the “Co-investments,” collectively with the Fund, are each a “Client” and
collectively the “Clients”).
Item 4.B.
IHP pursues its investment strategy through managing its Clients’ portfolios. IHP has
discretion with respect to investment decisions made for the Clients. The Adviser provides
investment advisory services to its Clients based on the investment objectives and strategies
described in each Client’s respective confidential offering memorandum and governing
documents (referred to collectively as “Offering Documents”).
IHP’s investment objective is to achieve long-term capital appreciation of investments in the
medical device industry.
IHP expects to target investments on a global basis, principally in early
to mid-stage, post-commercialization, privately held businesses, and expects investments to be
made in the form of equity.
IHP does not limit its advisory services to certain types of securities as outlined in each Client’s
investment management agreement.
Item 4.C.
IHP provides investment advisory services in accordance with the relevant Client investment
management agreement and Offering Documents. IHP will not tailor its advisory services to the
individual needs of its Clients’ underlying investors. Underlying investors also cannot impose
restrictions on the investment activities of the Clients. While there is a Fund Advisory Committee
(“Limited Partner Advisory Committee”) comprised of Fund investors that consults with IHP
concerning the Fund’s activities and operations as to business matters, including conflicts of
interest, this committee does not take part in the management or control of the Fund.
Item 4.D.
IHP does not participate in wrap fee programs.
Item 4.E.
As of December 31, 2023, IHP has approximately $213M of discretionary assets under
management. IHP does not manage any assets on a non-discretionary basis.